FDA Approves Opdivo-Yervoy Combo as First-Line Therapy for Inoperable Mesothelioma
News
The U.S. Food and Drug Administration (FDA) has approved a combination of Opdivo (nivolumab) and Yervoy (ipilimumab) as a first-line therapy for adults with inoperable malignant pleural mesothelioma (MPM), a rare but aggressive cancer ... Read more